Zelin Sheng(盛泽林)

Zelin Sheng(盛泽林), listed as board member, appears in our data through filings on 泽璟制药 shares, published by SSE / SZSE (CSRC). Over a trading history stretching from 3 March 2022 to 16 April 2026, the count stands at 8 filings.

The open-market side counts 7 purchases for €1.4M alongside 1 sale for €3.5M. Taken together, the sales exceed the purchases by €2.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings no purchases and 1 sale.

Half of the purchases are above €111k and half below. Clusters matter here: 4 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 16 April 2026: an open-market sale of €3.5M, in 泽璟制药. The most recent open-market purchase was published on 24 May 2022, 1,629 days ago. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.